Pharmaceutical composition for preventing and treating diseases caused by primary immune deficiences
CA 1332222 C · Owner: Boehringer Ingelheim International Gmbh · Inventors: Fasth, Anders
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a pharmaceutical composition containing interferon gamma (IFN.gamma.) for preventing and treating diseases caused by primary immune deficiencies. The pharmaceutical composition is directed particularly at diseases which may occur regularly or sporadically because of a "severe combined immune deficiency (SCID)".
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted October 4, 1994. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended October 4, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.